These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19151471)

  • 1. Feasibility and safety of autologous intracoronary stem cell transplantation in patients of non ischemic dilated cardiomyopathy.
    Nair M; Mukherjee S; Ahluwalia NS; Vaid AK; Kumar N
    Indian Heart J; 2007; 59(6):511-4. PubMed ID: 19151471
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy.
    Vrtovec B; Poglajen G; Sever M; Lezaic L; Domanovic D; Cernelc P; Haddad F; Torre-Amione G
    J Card Fail; 2011 Apr; 17(4):272-81. PubMed ID: 21440864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications after intracoronary stem cell transplantation in idiopathic dilated cardiomyopathy.
    Widimsky P; Penicka M
    Int J Cardiol; 2006 Jul; 111(1):178-9. PubMed ID: 16325290
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intracoronary autologous bone marrow-derived stem cell transplantation in patients with ischemic cardiomyopathy: results of 18-month follow-up].
    Tayyareci Y; Umman B; Sezer M; Beşişik S; Sanli Y; Mudun A; Gürses N; Nişanci Y
    Turk Kardiyol Dern Ars; 2008 Dec; 36(8):519-29. PubMed ID: 19223717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular autotransplantation for ischemic and idiopathic dilated cardiomyopathy. Preliminary report.
    Argüero R; Careaga-Reyna G; Castaño-Guerra R; Garrido-Garduño MH; Magaña-Serrano JA; de Jesús Nambo-Lucio M
    Arch Med Res; 2006 Nov; 37(8):1010-4. PubMed ID: 17045119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I Clinical Trial of Autologous Stem Cell-Sheet Transplantation Therapy for Treating Cardiomyopathy.
    Miyagawa S; Domae K; Yoshikawa Y; Fukushima S; Nakamura T; Saito A; Sakata Y; Hamada S; Toda K; Pak K; Takeuchi M; Sawa Y
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28381469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramyocardial angiogenic cell precursors in nonischemic dilated cardiomyopathy.
    Arom KV; Ruengsakulrach P; Belkin M; Tiensuwan M
    Asian Cardiovasc Thorac Ann; 2009 Aug; 17(4):382-8. PubMed ID: 19713335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study.
    Beitnes JO; Hopp E; Lunde K; Solheim S; Arnesen H; Brinchmann JE; Forfang K; Aakhus S
    Heart; 2009 Dec; 95(24):1983-9. PubMed ID: 19833610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stem cells transplantation on dilated cardiomyopathy].
    Wang JA; Xie XJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Mar; 34(3):200-1. PubMed ID: 16630448
    [No Abstract]   [Full Text] [Related]  

  • 10. Idiopathic Dilated Cardiomyopathy Treated With Intracoronary Infusion of Autologous Bone Marrow Cells: Long-term Follow-up.
    Baeza Garzón F; Romero M; Suárez de Lezo J; Ojeda Pineda S; Herrera C; Suárez de Lezo J
    Rev Esp Cardiol (Engl Ed); 2015 Aug; 68(8):726-8. PubMed ID: 26111619
    [No Abstract]   [Full Text] [Related]  

  • 11. Necrobiotic xanthogranuloma successfully treated with autologous stem cell transplantation.
    Goede JS; Misselwitz B; Taverna C; Schanz U; Dispenzieri A; Hummel Y; Trüeb RM; Fehr J
    Ann Hematol; 2007 Apr; 86(4):303-6. PubMed ID: 17216474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of the patients after stem cell transplantation for pediatric dilated cardiomyopathy.
    Bergmane I; Lacis A; Lubaua I; Jakobsons E; Erglis A
    Pediatr Transplant; 2013 May; 17(3):266-70. PubMed ID: 23458132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction for intracoronary cell infusion.
    Chang SA; Kang HJ; Lee HY; Kim KH; Hur J; Han KS; Park YB; Kim HS
    Heart; 2009 Aug; 95(16):1326-30. PubMed ID: 19460773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma.
    Andersen NS; Pedersen LB; Laurell A; Elonen E; Kolstad A; Boesen AM; Pedersen LM; Lauritzsen GF; Ekanger R; Nilsson-Ehle H; Nordström M; Fredén S; Jerkeman M; Eriksson M; Väärt J; Malmer B; Geisler CH
    J Clin Oncol; 2009 Sep; 27(26):4365-70. PubMed ID: 19652064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiac regeneration therapy to ischemic cardiomyopathy].
    Takehara N; Matsubara H
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():451-6. PubMed ID: 22724246
    [No Abstract]   [Full Text] [Related]  

  • 16. Intracoronary administration of autologous mesenchymal stem cells in a critically ill patient with dilated cardiomyopathy.
    Zeinaloo A; Zanjani KS; Bagheri MM; Mohyeddin-Bonab M; Monajemzadeh M; Arjmandnia MH
    Pediatr Transplant; 2011 Dec; 15(8):E183-6. PubMed ID: 20880092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell therapy in dilated cardiomyopathy: from animal models to clinical trials.
    Del Corsso C; Campos de Carvalho AC
    Braz J Med Biol Res; 2011 May; 44(5):388-93. PubMed ID: 21503415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial homing and coronary endothelial function after autologous blood CD34+ progenitor cells intracoronary injection in the chronic phase of myocardial infarction.
    Dedobbeleer C; Blocklet D; Toungouz M; Lambermont M; Unger P; Degaute JP; Goldman S; Berkenboom G
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):480-5. PubMed ID: 19433985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potentials of stem cells in cardiac diseases.
    Strauer BE; Schannwell CM; Brehm M
    Minerva Cardioangiol; 2009 Apr; 57(2):249-67. PubMed ID: 19274033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia.
    Ferrara F; Mele G; Palmieri S; Pedata M; Copia C; Riccardi C; Izzo T; Criscuolo C; Musto P
    Hematol Oncol; 2009 Dec; 27(4):198-202. PubMed ID: 19475701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.